Jennifer L. Dreyer, Ph.D.
With over 8+ years of expertise in health and medicine as a PhD-level professional medical writer, I deliver you and your client high-quality scientific content in a variety of online and offline formats. My services include providing superior work on time and on budget, while ensuring that your clients’ visions and expectations are fulfilled.
Sample Therapeutic Areas of Expertise
• Heart failure
• Solid Organ Transplantation
2012–present, Freelance Medical Writer
• Participates in strategic planning and project meetings with internal and client teams as needed, gathering information and assessing client expectations on assigned initiatives to connect science with strategy.
• Develops and edits materials in a variety of end-project formats, from slide kits to expert videos to animations all while following the clients’ annotation requirements.
• Attends global scientific symposia and advisory board meetings, sometimes juggling over 15+ presentations and their respective presenters per meeting as the solo clinical expert.
• Liaises with KOLs to develop presentation outlines, prepare first drafts, and incorporate KOL amendments. Ensures quality of deliverables by confirming adherence to guidelines and pushes decks through a multi-tiered review process.
• Manages slide review sessions onsite with KOLs to ensure deliverable perfection. Captures feedback from delegates and KOLs to be relayed to the client post-meeting.
2010–2012, Managing Editor, Expert Medical Education
• Performed literature review and content development for quarterly or monthly client-, healthcare professional- or patient-facing newsletters.
• Developed learning objectives and test questions for CME-related content
• Coordinated with editorial board to obtain approval of content. Pushed CME-related material through the accreditation process. Selected artwork, reviewed layouts, approved printer proofs, released final approved versions to Web host, and managed email blasts and final print production. Oversaw faculty honoraria and vendor payments.
• For onsite conference coverage, responsibilities included (1) attending preselected poster and/or oral presentation sessions, (2) coordinating with the team in real time to determine depth and breadth of onsite coverage, (3) drafting meeting coverage while onsite for email blasts and (4) completing additional in-depth coverage upon return.
• Fleshed-out pre-existing outlines based upon literature review for podcast development. Identified and invited experts for an interview. Digitally captured interviews, delegated transcriptions, edited audio files, and obtained interviewers’ approvals. Pushed podcasts live on Web host.
2008–2010, Freelance Medical Writer/Editor
• Medical Writing:
Writer, Hyponatremia Pocket-Guide
o Attended a two-day “Salt Summit” along with cardiologists, hepatologists, nephrologists, hospitalists, endocrinologists and pharmacists to develop guidelines to identify and treat chronic vs acute hyponatremia
o Wrote a 92-page guide for the management of in-hospital hyponatremia.
o Wrote web-based copy on a variety of health topics, such as women’s health, PTSD and anxiety, that included keywords and meta-tags
• Medical Editing: Revised over 300 scientific journal articles spanning a wide variety of topics, such as gastroenterology, hepatology, neurology, oncology, and pharmacology, written by non-native English writers (Turnaround time < 36 hours).
1997 BE Chemical Engineering Vanderbilt University, Nashville, TN
2007 PhD Pharmacology/Toxicology University of Arkansas for Medical Sciences,
Little Rock, AR
2007–2008 Post-doctoral Fellow Emory University, Atlanta, GA
Software: Adobe Acrobat, ImagePro and Photoshop; Microsoft Word, Excel, and PowerPoint; Reference Manager; Endnote; and GraphPad Prism.
Member: American Medical Writers Association, American Writers and Artists, Inc.
Peer-Reviewed Publications: (written under my previous name, Jennifer L. Shoemaker)
* manuscript writer
† Journal supplement
• Saunders C, Caon C, Smrtka J, Shoemaker J†. Factors that influence adherence and strategies to maintain adherence to injected therapies for patients with multiple sclerosis. J Neurosci Nurs. 2010; 42:S10–8.
• Caon C, Saunders C, Smrtka J, Baxter N, Shoemaker J†. Injectable disease-modifying therapy for relapsing-remitting multiple sclerosis: a review of adherence data. J Neurosci Nurs. 2010; 42:S5–9.
• Rammohan KW, Shoemaker J*†. Emerging multiple sclerosis oral therapies. Neurology. 2010; 74:S47–53.
• Kasper LH, Shoemaker J*†. Multiple sclerosis immunology: The healthy immune system vs the MS immune system. Neurology. 2010; 74:S2–8.
• Shoemaker JL*, Seely KA, Reed RL, Crow JP, Prather PL. The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis (ALS) when initiated at symptom onset. J Neurochem. 2007; 101:87–98.
• Dorman RB, Wunder C, Saba H, Shoemaker JL, MacMillan-Crow LA, Brock RW. NAD(P)H oxidase contributes to the progression of remote hepatic parenchymal injury and endothelial dysfunction, but not microvascular perfusion deficits. Am J Physiol Gastrointest Liver Physiol. 2006; 290:G1025–32.
• Shoemaker JL*, Ruckle MB, Mayeux PR, Prather PL. Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors. J Pharmacol Exp Ther, 2005; 315:828–38.
• Shoemaker JL*, Joseph BK, Ruckle MB, Mayeux PR, Prather PL. The endo-cannabinoid noladin ether acts as a full agonist at human CB2 receptors. J Pharmacol Exp Ther, 2005; 314:868–75.